RASSF1 and head and neck squamous cell carcinoma: Overall, the pooled OR of RASSF1A methylation in cancer tissues and controls under the random-effects model was 2.93 (95% CI: 1.58–5.46), which suggested a significant association of the methylation of RASSF1A promoter with HNSCC.